The latest research in oncology focuses on the use of immune system suppressors, specifically immuno-suppressants. It has been known for decades that the immune system plays a crucial role in combating various diseases. From simple colds and flu to more serious illnesses such as cancer and multiple sclerosis, the immune system plays a key role in our health and well being. A recent study shows that immunotherapy, in the form of multiple sclerosis drugs, may be the perfect solution for boosting the immune system and preventing the onset of this debilitating disease.
Multiple sclerosis is a slow developing disorder that slowly destroys the myelin sheath in the brain and spinal cord. When myeloma reaches an advanced stage, it can cause severe physical disability and a poor quality of life. Recent studies have shown promise, that by using an immunotherapy approach, the myeloma can be prevented from progressing any further. With the latest research and success in the development of new agents, it is now possible for patients with established myeloma to receive ongoing treatment even when they are in the advanced stages of the disease. This is important because, as the disease progresses, the myeloma may not respond favorably to conventional treatments.
Immunotherapy is based on the fact that T cells, or white blood cells, are the only cells that can kill the leukemia virus. These cells are unique, as they are able to attack cancer cells without harming healthy tissue. Although it is not fully understood how this works, new drugs such as leukotriene modifiers, or inhibitors, appear to be more effective than antibodies in terms of achieving this end. In addition, new drugs such as checkpoint inhibitors allow for the rapid maintenance of remission when multiple sclerosis is present. Remark inhibitors stop the production of a chemical messenger called cyclic AMP, which normally contributes to the development of symptoms of multiple sclerosis. Due to the extreme importance of the cyclic AMP pathway in the regulation of multiple sclerosis, the development of potent new drugs is very exciting.
Another exciting clinical trial using T-cell immunotherapy to treat myeloma is being conducted at the University of Wisconsin-Madison. There, researchers are studying how to use myeloma cells in the quest to discover a cure for various chronic illnesses. The ultimate goal is to generate a drug that will destroy all myeloma cells, but until that day comes, there are ways to control and keep myeloma cells from multiplying. For many years, scientists have been trying to develop a way to actually give immune cells the ability to kill off cancerous cells.
New research has discovered that certain compounds in an experimental drug called amitriptyline can help myeloma patients reduce their own immune system attacks against their disease. This compound is taken directly into the myeloma regions in order to inhibit the production of antibodies, which in turn prevents the myeloma cells from multiplying. With continuous clinical trials and positive results, this promising new medication could soon become a part of the treatment regimen of millions of myeloma patients. Although it may take several more years before this treatment becomes widely available to the public, for patients suffering from the debilitating effects of myeloma, it is a step in the right direction.
Regardless of what type of treatment a patient decides on for his or her condition, finding the latest information is crucial for ongoing treatment. With a vast amount of new drugs and clinical trials being conducted around the world every day, it’s important for patients to understand what they can expect from their physicians. While no one likes to think about their condition, knowing the latest research about multiple myeloma is an essential part of living with the disease. Even if you’ve already been diagnosed with the condition, your doctor should inform you about any new studies that may affect your treatment options. As previously stated, multiple myeloma is a very difficult condition to treat, and taking every step possible to prevent further myeloma cell creation is crucial.